Report me for selling fake medicine? Why are you crying when your illness relapses?

But when everyone was feeling pessimistic about this,

Suddenly, a piece of news spread quickly throughout the entire Internet.

That is, Chen Xuan rejected AbbVie's acquisition, the two parties did not reach an agreement, and eventually parted ways unhappily.

As soon as this news came out, the entire Internet was in an uproar.

"What? Aibowei was rejected by Chen Xuan?"

"What price did Abovi offer? Are they trying to undercut me? Otherwise, why would they refuse?"

"Bullshit bargaining! AbbVie directly offered 20 billion to acquire the formula patent, but was still rejected by Chen Xuan."

"Holy crap, 200 billion for a formula. What he said to the central bank before really wasn't an exaggeration!"

"It's more than 20 billion. AbbVie is offering 32 billion to acquire the formula patent and 60% of Antai Pharmaceutical Group's shares."

"Holy crap, is AbbVie's offer that generous? Compared to Changfeng Group's offer of only 100 billion yuan, the difference is truly stark!"

"Compared to the lavish investments of foreign companies, our Chinese pharmaceutical companies are really small-scale. No wonder they are looked down upon. They simply don't understand the value of their products."

"I heard Chen Xuan also made an offer, but his price was a bit high, which scared away the AbbVie delegation."

For a moment, the entire Internet was boiling.

The main reason is that the news was too shocking, and everyone couldn't help but be shocked.

It was originally thought that AbbVie's acquisition of Aetna Pharmaceuticals would go smoothly, but it was unexpected that it would be rejected so decisively.

The information exposed this time also revealed AbbVie's offer, including the offer for the patent of a special lung cancer drug and the offer for Antai Pharmaceutical Group.

When everyone knew that AbbVie planned to spend 320 billion yuan to acquire the formula of a special lung cancer drug and 60% of the shares of Antai Pharmaceutical Group, they had to sigh at AbbVie's wealth.

After all, Changfeng Group is only willing to spend 100 billion to acquire the formula, or 120 billion to acquire 60% of Antai Pharmaceutical Group's shares.

The bids of the two are indeed very different in comparison.

Changfeng Group's offer seems to lack sincerity, and it seems that they are trying to take advantage of the opportunity to get a bargain.

However, what shocked countless netizens the most was not AbbVie's sky-high acquisition price, but Chen Xuan's rejection without hesitation.

This is what makes everyone unbelievable the most. They don't believe that he can refuse such a high price.

After knowing this result,

Countless people are also very curious about how much money Chen Xuan intends to ask for to sell the new drug formula?

He gave AbbVie a price at the time, but scared the other party away.

So what will the price be?

……

“AbbVie also failed?”

"We haven't reached an agreement on a 320 billion yuan offer yet?"

After hearing the news, Qin Guoming, who had been staying in the hotel, was completely stunned.

After hearing about AbbVie's move, he already felt that he had no chance of success.

After all, AbbVie is very wealthy, and Changfeng Group is really not up to par. The gap in strength between the two is too great.

Facing such a powerful competitor, he really felt that he had no chance of winning.

So, when Qin Guoming heard that the AbbVie delegation had already set off, he was already considering leaving Jiujiang and abandoning the project.

But just as he was about to leave, he heard the news that AbbVie had also failed.

This made him feel unbelievable that there was a formula that even AbbVie couldn't get.

"If AbbVie's negotiations fail, we still have a chance."

"But Chen Xuan has such a big appetite. Can I really satisfy him?"

Frowning, Qin Guoming began to think.

AbbVie couldn't get Chen Xuan's new drug formula.

It's good news for him, but also bad news.

The good news is of course that if AbbVie fails, Changfeng Group will still have a chance to compete instead of withdrawing directly.

The bad news is that even AbbVie has failed. Can he offer a higher price than AbbVie?

This time, AbbVie paid 320 billion yuan.

Moreover, the formula for the lung cancer-specific drug alone has a bid of 20 billion yuan.

Qin Guoming was helpless about this sky-high price.

The most important thing is that Chen Xuan is not even tempted by 20 billion yuan. How much more money can he offer to satisfy the other party?

"Go and investigate. Make sure you find out what Chen Xuan's final offer was."

Qin Guoming instructed the secretary Ouyang Yue beside him.

Now he just wants to know the specific bid.

If he knew the price Chen Xuan offered at the time, he would be able to judge whether he had a chance to compete.

……